Aldeyra Therapeutics Inc

NASDAQ:ALDX   3:59:54 PM EDT
2.63
+0.17 (+6.91%)
Earnings Announcements

Aldeyra Therapeutics Reports Full-Year 2021 Financial Results, Recent Corporate Highlights

Published: 03/17/2022 11:20 GMT
Aldeyra Therapeutics Inc (ALDX) - Aldeyra Therapeutics Reports Full-year 2021 Financial Results and Recent Corporate Highlights.
Aldeyra Therapeutics Inc - Reports Full-year 2021 Financial Results and Recent Corporate Highlights.
Aldeyra Therapeutics Inc - Cash and Cash Equivalents of $229.8 Million As of December 31, 2021; Projected Cash Runway Through 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.